|
Volumn 14, Issue 1, 2003, Pages 92-111
|
Identification and management of delirium in the critically ill patient with cancer.
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ANXIOLYTIC AGENT;
BENZODIAZEPINE DERIVATIVE;
NEUROLEPTIC AGENT;
DELIRIUM;
DIFFERENTIAL DIAGNOSIS;
HUMAN;
MENTAL DISEASE;
NEOPLASM;
NOMENCLATURE;
PATHOPHYSIOLOGY;
REVIEW;
RISK FACTOR;
ANTI-ANXIETY AGENTS;
ANTIPSYCHOTIC AGENTS;
BENZODIAZEPINES;
DELIRIUM;
DIAGNOSIS, DIFFERENTIAL;
HUMANS;
MENTAL DISORDERS;
NEOPLASMS;
RISK FACTORS;
TERMINOLOGY;
|
EID: 0037312339
PISSN: 10790713
EISSN: None
Source Type: Journal
DOI: 10.1097/00044067-200302000-00011 Document Type: Review |
Times cited : (8)
|
References (88)
|